AHRQ Director Defends U.S. Preventive Services Task Force

Amid wide public outcry over new advice against routine screening for prostate cancer with prostate-specific antigen blood tests, Agency for Healthcare Research and Quality Director Carolyn Clancy is defending both the draft recommendations and the group that issued them, the U.S. Preventive Services Task Force.